Search

Author/Creator Teng, Michele W. L.

1. CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity. (4th May 2018)

Authors:
Roman Aguilera, Amelia; Lutzky, Viviana P.; Mittal, Deepak; Li, Xian-Yang; Stannard, Kimberley; Takeda, Kazuyoshi; Bernhardt, Günter; Teng, Michele W. L.; Dougall, William C.; Smyth, Mark J.
Journal:
Oncoimmunology
Issue:
Volume 7:Number 5(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. (3rd July 2018)

Authors:
Harjunpää, Heidi; Blake, Stephen J.; Ahern, Elizabeth; Allen, Stacey; Liu, Jing; Yan, Juming; Lutzky, Viviana; Takeda, Kazuyoshi; Aguilera, Amy Roman; Guillerey, Camille; Mittal, Deepak; Li, Xian Yang; Dougall, William C.; Smyth, Mark J.; Teng, Michele W. L.
Journal:
Oncoimmunology
Issue:
Volume 7:Number 7(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗